Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population
Abstract INTRODUCTION: The trivalent inactivated influenza vaccine was approved for use in Turkey during the 2018-2019 influenza season. We evaluated beliefs regarding the vaccine and vaccination outcomes in a Turkish population. METHODS: Individuals who were vaccinated with the trivalent inactiva...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2020-09-01
|
| Series: | Revista da Sociedade Brasileira de Medicina Tropical |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100335&tlng=en |
| _version_ | 1828338925099286528 |
|---|---|
| author | Guzin Zeren Ozturk Seda Ozmen Memet Taskin Egici Ekmel Burak Ozsenel |
| author_facet | Guzin Zeren Ozturk Seda Ozmen Memet Taskin Egici Ekmel Burak Ozsenel |
| author_sort | Guzin Zeren Ozturk |
| collection | DOAJ |
| description | Abstract INTRODUCTION: The trivalent inactivated influenza vaccine was approved for use in Turkey during the 2018-2019 influenza season. We evaluated beliefs regarding the vaccine and vaccination outcomes in a Turkish population. METHODS: Individuals who were vaccinated with the trivalent inactivated influenza vaccine between November 1 and December 31, 2018, at the Sisli Hamidiye Training and Research Hospital in Istanbul, Turkey, were included in this study. A 15-item questionnaire was completed by a physician during a face-to-face interview with the participants. All participants were followed during the 2018-2019 influenza season through May 2019. The participants were instructed to consult the same physician in case of sudden illness. Participants’ beliefs and outcomes were assessed by their vaccination status for the 2017-2018 influenza season. RESULTS: A total of 150 participants were recruited. Their median age was 66 (range, 22-88) years. During the 2017-2018 influenza season, 4.1% had been hospitalized, 53.5% had developed an upper respiratory disease (URD), and 16.2% had been diagnosed with pneumonia. There were no cases of influenza, pneumonia, or hospitalization in the 2019 season; 49.3% of the participants developed a URD (n = 74). Among participants who had been vaccinated during both influenza seasons, 47.5% had had and/or developed a URD, with a higher number of cases during the 2018-2019 season. CONCLUSIONS: After vaccination, no cases of influenza, hospitalization, and pneumonia were observed and the incidence of URD decreased compared with that of the previous season. |
| first_indexed | 2024-04-13T22:35:52Z |
| format | Article |
| id | doaj.art-ffe5fd172e6f4db7bb36ec982fb60ee9 |
| institution | Directory Open Access Journal |
| issn | 1678-9849 |
| language | English |
| last_indexed | 2024-04-13T22:35:52Z |
| publishDate | 2020-09-01 |
| publisher | Sociedade Brasileira de Medicina Tropical (SBMT) |
| record_format | Article |
| series | Revista da Sociedade Brasileira de Medicina Tropical |
| spelling | doaj.art-ffe5fd172e6f4db7bb36ec982fb60ee92022-12-22T02:26:47ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98492020-09-015310.1590/0037-8682-0605-2019Results of Influenza Vaccination: Short Follow-Up Study of a Turkish PopulationGuzin Zeren OzturkSeda Ozmenhttps://orcid.org/0000-0002-2451-6074Memet Taskin EgiciEkmel Burak OzsenelAbstract INTRODUCTION: The trivalent inactivated influenza vaccine was approved for use in Turkey during the 2018-2019 influenza season. We evaluated beliefs regarding the vaccine and vaccination outcomes in a Turkish population. METHODS: Individuals who were vaccinated with the trivalent inactivated influenza vaccine between November 1 and December 31, 2018, at the Sisli Hamidiye Training and Research Hospital in Istanbul, Turkey, were included in this study. A 15-item questionnaire was completed by a physician during a face-to-face interview with the participants. All participants were followed during the 2018-2019 influenza season through May 2019. The participants were instructed to consult the same physician in case of sudden illness. Participants’ beliefs and outcomes were assessed by their vaccination status for the 2017-2018 influenza season. RESULTS: A total of 150 participants were recruited. Their median age was 66 (range, 22-88) years. During the 2017-2018 influenza season, 4.1% had been hospitalized, 53.5% had developed an upper respiratory disease (URD), and 16.2% had been diagnosed with pneumonia. There were no cases of influenza, pneumonia, or hospitalization in the 2019 season; 49.3% of the participants developed a URD (n = 74). Among participants who had been vaccinated during both influenza seasons, 47.5% had had and/or developed a URD, with a higher number of cases during the 2018-2019 season. CONCLUSIONS: After vaccination, no cases of influenza, hospitalization, and pneumonia were observed and the incidence of URD decreased compared with that of the previous season.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100335&tlng=enUpper respiratory diseaseInfluenzaInfluenza vaccinationTurkey |
| spellingShingle | Guzin Zeren Ozturk Seda Ozmen Memet Taskin Egici Ekmel Burak Ozsenel Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population Revista da Sociedade Brasileira de Medicina Tropical Upper respiratory disease Influenza Influenza vaccination Turkey |
| title | Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population |
| title_full | Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population |
| title_fullStr | Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population |
| title_full_unstemmed | Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population |
| title_short | Results of Influenza Vaccination: Short Follow-Up Study of a Turkish Population |
| title_sort | results of influenza vaccination short follow up study of a turkish population |
| topic | Upper respiratory disease Influenza Influenza vaccination Turkey |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100335&tlng=en |
| work_keys_str_mv | AT guzinzerenozturk resultsofinfluenzavaccinationshortfollowupstudyofaturkishpopulation AT sedaozmen resultsofinfluenzavaccinationshortfollowupstudyofaturkishpopulation AT memettaskinegici resultsofinfluenzavaccinationshortfollowupstudyofaturkishpopulation AT ekmelburakozsenel resultsofinfluenzavaccinationshortfollowupstudyofaturkishpopulation |